BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26351325)

  • 1. Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies.
    Calpe S; Wagner K; El Khattabi M; Rutten L; Zimberlin C; Dolk E; Verrips CT; Medema JP; Spits H; Krishnadath KK
    Mol Cancer Ther; 2015 Nov; 14(11):2527-40. PubMed ID: 26351325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors.
    Calpe S; Correia AC; Sancho-Serra Mdel C; Krishnadath KK
    MAbs; 2016; 8(4):678-88. PubMed ID: 26967714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.
    Li S; Hoefnagel SJM; Read M; Meijer S; van Berge Henegouwen MI; Gisbertz SS; Bonora E; Liu DSH; Phillips WA; Calpe S; Correia ACP; Sancho-Serra MDC; Mattioli S; Krishnadath KK;
    Cell Oncol (Dordr); 2022 Aug; 45(4):639-658. PubMed ID: 35902550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of zebrafish bone morphogenetic proteins 2, 4 and 16: molecular and evolutionary perspectives.
    Marques CL; Fernández I; Viegas MN; Cox CJ; Martel P; Rosa J; Cancela ML; Laizé V
    Cell Mol Life Sci; 2016 Feb; 73(4):841-57. PubMed ID: 26341094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific expression of BMP2/4 ortholog in biomineralizing tissues of corals and action on mouse BMP receptor.
    Zoccola D; Moya A; Béranger GE; Tambutté E; Allemand D; Carle GF; Tambutté S
    Mar Biotechnol (NY); 2009; 11(2):260-9. PubMed ID: 18795368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
    Upton PD; Long L; Trembath RC; Morrell NW
    Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling.
    Lin YC; Niceta M; Muto V; Vona B; Pagnamenta AT; Maroofian R; Beetz C; van Duyvenvoorde H; Dentici ML; Lauffer P; Vallian S; Ciolfi A; Pizzi S; Bauer P; Grüning NM; Bellacchio E; Del Fattore A; Petrini S; Shaheen R; Tiosano D; Halloun R; Pode-Shakked B; Albayrak HM; Işık E; Wit JM; Dittrich M; Freire BL; Bertola DR; Jorge AAL; Barel O; Sabir AH; Al Tenaiji AMJ; Taji SM; Al-Sannaa N; Al-Abdulwahed H; Digilio MC; Irving M; Anikster Y; Bhavani GSL; Girisha KM; ; Haaf T; Taylor JC; Dallapiccola B; Alkuraya FS; Yang RB; Tartaglia M
    Am J Hum Genet; 2021 Jan; 108(1):115-133. PubMed ID: 33308444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals.
    Lintern KB; Guidato S; Rowe A; Saldanha JW; Itasaki N
    J Biol Chem; 2009 Aug; 284(34):23159-68. PubMed ID: 19553665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
    Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM
    Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.
    Nickel J; Dreyer MK; Kirsch T; Sebald W
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 1):S7-14. PubMed ID: 11263668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions.
    Kloen P; Lauzier D; Hamdy RC
    Bone; 2012 Jul; 51(1):59-68. PubMed ID: 22521262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis.
    Bandyopadhyay A; Tsuji K; Cox K; Harfe BD; Rosen V; Tabin CJ
    PLoS Genet; 2006 Dec; 2(12):e216. PubMed ID: 17194222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin-1 (TSP-1), a new bone morphogenetic protein-2 and -4 (BMP-2/4) antagonist identified in pituitary cells.
    Sallon C; Callebaut I; Boulay I; Fontaine J; Logeart-Avramoglou D; Henriquet C; Pugnière M; Cayla X; Monget P; Harichaux G; Labas V; Canepa S; Taragnat C
    J Biol Chem; 2017 Sep; 292(37):15352-15368. PubMed ID: 28747434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP10 as a potent inducer of trophoblast differentiation in human embryonic and induced pluripotent stem cells.
    Lichtner B; Knaus P; Lehrach H; Adjaye J
    Biomaterials; 2013 Dec; 34(38):9789-802. PubMed ID: 24070570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
    Jiramongkolchai P; Owens P; Hong CC
    Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.
    Alarmo EL; Kuukasjärvi T; Karhu R; Kallioniemi A
    Breast Cancer Res Treat; 2007 Jun; 103(2):239-46. PubMed ID: 17004110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.
    Nolan K; Kattamuri C; Luedeke DM; Angerman EB; Rankin SA; Stevens ML; Zorn AM; Thompson TB
    J Biol Chem; 2015 Feb; 290(8):4759-4771. PubMed ID: 25561725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.